Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years
- Journal:
- JAMA: The Journal of the American Medical Association
- Published:
- Affiliations:
- 4
- Authors:
- 19
| Institutions | Authors | Share |
|---|---|---|
| Moderna, United States of America (USA) | 0.84 | |
| Indago, United States of America (USA) | 0.05 | |
| Revival Research Corporation, United States of America (USA) | 0.05 | |
| CenExel Clinical Research, United States of America (USA) | 0.05 |